 Supernus Pharmaceuticals, Inc. NASDAQ:SUPN Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler Ken Cacciatore - Cowen Operator Good afternoon and welcome to Supernus Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. Operator Instructions As a reminder, this conference call is being recorded. 